National Clinical Research Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China.
JAMA Netw Open. 2021 Jan 4;4(1):e2031669. doi: 10.1001/jamanetworkopen.2020.31669.
The relationship of dietary niacin intake with the risk of hypertension remains unknown.
To determine the prospective association between dietary niacin intake and new-onset hypertension, and examine factors that may modify the association among Chinese adults.
DESIGN, SETTING, AND PARTICIPANTS: This nationwide cohort study of 12 243 Chinese adults used dietary intake data from 7 rounds of the China Health and Nutrition Survey. Dietary intake was measured by 3 consecutive 24-hour dietary recalls from participants in combination with a weighing inventory taken over the same 3 days at the household level. Statistical analysis was conducted from May 2020 to August 2020.
Dietary intake.
The study outcome was new-onset hypertension, defined as systolic blood pressure 140 mm Hg or greater and/or diastolic blood pressure 90 mm Hg or greater, diagnosis by physician, or current antihypertensive treatment during the follow-up.
The mean (SD) age of the study population was 41.2 (14.2) years, and 5728 (46.8%) of participants were men. The mean (SD) dietary niacin intake level was 14.8 (4.1) mg/d. A total of 4306 participants developed new-onset hypertension during a median (interquartile range) follow-up duration of 6.1 (3.6-11.3) years. When dietary niacin was assessed in quartiles, the lowest risk of new-onset hypertension was found in participants in quartile 3 (14.3 to <16.7 mg/d; adjusted hazard ratio, 0.83; 95% CI, 0.75-0.90) compared with those in quartile 1 (<12.4 mg/d). Consistently in the threshold analysis, for every 1 mg/d increase in dietary niacin, there was a 2% decrease in new-onset hypertension (adjusted HR, 0.98; 95% CI, 0.96-1.00) in those with dietary niacin intake less than 15.6 mg/d, and a 3% increase in new-onset hypertension (adjusted HR, 1.03; 95% CI, 1.02-1.04) in participants with dietary niacin 15.6 mg/d or greater. Based on these results, there was a J-shaped association between dietary niacin intake and new-onset hypertension in the general population of Chinese adults, with an inflection point at 15.6 mg/d and a minimal risk at 14.3 to 16.7 mg/d (quartile 3) of dietary niacin intake.
The results of this study provide some evidence for maintaining the optimal dietary niacin intake levels for the primary prevention of hypertension.
膳食烟酸摄入量与高血压风险之间的关系尚不清楚。
确定中国成年人中膳食烟酸摄入与新发高血压之间的前瞻性关联,并研究可能改变这种关联的因素。
设计、地点和参与者:这是一项全国性的队列研究,纳入了 12243 名中国成年人,使用了 7 轮中国健康与营养调查中的饮食摄入数据。通过参与者连续 3 天的 3 次 24 小时饮食回忆,并结合家庭层面的 3 天称重库存,对饮食摄入进行了测量。统计分析于 2020 年 5 月至 2020 年 8 月进行。
膳食摄入。
研究结果为新发高血压,定义为收缩压 140mmHg 或更高和/或舒张压 90mmHg 或更高、由医生诊断、或在随访期间接受当前降压治疗。
研究人群的平均(SD)年龄为 41.2(14.2)岁,5728 名(46.8%)参与者为男性。平均(SD)膳食烟酸摄入量为 14.8(4.1)mg/d。中位(四分位间距)随访 6.1(3.6-11.3)年后,共有 4306 名参与者发生新发高血压。当按四分位数评估膳食烟酸时,与第 1 四分位数(<12.4mg/d)相比,第 3 四分位数(14.3 至<16.7mg/d)的参与者新发高血压的风险最低(调整后的 HR,0.83;95%CI,0.75-0.90)。在阈值分析中,在摄入的烟酸少于 15.6mg/d 的人群中,烟酸摄入量每增加 1mg/d,新发高血压的风险降低 2%(调整后的 HR,0.98;95%CI,0.96-1.00),而在摄入烟酸 15.6mg/d 或以上的人群中,新发高血压的风险增加 3%(调整后的 HR,1.03;95%CI,1.02-1.04)。基于这些结果,在中国成年人的一般人群中,膳食烟酸摄入与新发高血压之间呈 J 形关联,拐点在 15.6mg/d,最佳摄入量在 14.3 至 16.7mg/d(第 3 四分位数)。
这项研究的结果为维持最佳膳食烟酸摄入量以预防高血压提供了一些证据。